Artisan Partners Limited Partnership Has $90.94 Million Holdings in CME Group Inc. $CME

Artisan Partners Limited Partnership boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 336,572 shares of the financial services provider’s stock after buying an additional 5,588 shares during the quarter. Artisan Partners Limited Partnership owned about 0.09% of CME Group worth $90,938,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Amundi raised its stake in shares of CME Group by 24.0% in the second quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after purchasing an additional 385,225 shares in the last quarter. Truist Financial Corp boosted its stake in CME Group by 8.9% during the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after buying an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC increased its holdings in CME Group by 86.0% in the 3rd quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after buying an additional 13,512 shares during the period. Elevate Capital Advisors LLC lifted its holdings in shares of CME Group by 85.2% during the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after acquiring an additional 3,919 shares during the period. Finally, Victory Financial Group LLC lifted its holdings in shares of CME Group by 310.2% during the 2nd quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after acquiring an additional 2,302 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CME shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. TD Cowen increased their target price on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. UBS Group restated a “neutral” rating and set a $310.00 target price on shares of CME Group in a research report on Friday, February 6th. Piper Sandler boosted their price target on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Jefferies Financial Group dropped their price objective on CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $299.53.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction on Tuesday, December 30th. The stock was purchased at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders sold 30,248 shares of company stock valued at $8,355,450. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.0%

NASDAQ CME opened at $319.50 on Friday. The stock’s 50 day simple moving average is $287.63 and its 200 day simple moving average is $275.97. CME Group Inc. has a one year low of $248.53 and a one year high of $322.57. The firm has a market cap of $115.21 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 3.70 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.52 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.6%. The ex-dividend date is Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is 44.80%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.